Results 31 to 40 of about 174,241,193 (307)

Influenza-attributable years of life lost in older adults in a subtropical city in China, 2012–2017: A modeling study based on a competing risks approach

open access: yesInternational Journal of Infectious Diseases, 2020
Objective: The aim of this study was to estimate influenza-attributable years of life lost (YLL) in older adults in subtropical Hefei, China during the years 2012–2017, based on a competing risks approach.
Yajing Hao   +5 more
doaj   +1 more source

Globalization and life lost due to tuberculosis: evidence from a multi-country study [version 1; peer review: 2 approved, 1 approved with reservations]

open access: yesF1000Research, 2021
Background: Tuberculosis affects around 30% of the population of the world. Tuberculosis causes an increase in early mortality and thus has the potential to increase the number of years of life lost.
Shyamkumar Sriram, Muayad Albadrani
doaj   +1 more source

The impact of temperature on years of life lost in Brisbane, Australia

open access: yes, 2012
Temperature is an important determinant of health. A better knowledge of how temperature affects population health is important not only to the scientific community, but also to the decision-makers who develop and implement early warning systems and ...
Barnett, Adrian G.   +7 more
core   +1 more source

MORTALITY AND LOST YEARS OF LIFE AS A RESULT OF CARDIOVASCULAR PREMATURE DEATHS

open access: yesКардиоваскулярная терапия и профилактика, 2014
Aim. Disability and Life-Year Loss (DALYs) is an important healthcare indicator. The first step in DALYs estimation is the measurement of lost years of life due to premature death.
S. A. Boitsov, I. V. Samorodskaya
doaj   +1 more source

Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer

open access: yesBMC Medical Research Methodology, 2012
Background Disability-adjusted life years (DALYs) link data on disease occurrence to health outcomes, and they are a useful aid in establishing country-specific agendas regarding cancer control.
Soerjomataram Isabelle   +6 more
doaj   +1 more source

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

open access: yesBMC Public Health, 2023
Background Burden of disease estimates have become important population health metrics over the past decade to measure losses in health. In Belgium, the disease burden caused by COVID-19 has not yet been estimated, although COVID-19 has emerged as one of
Brecht Devleesschauwer   +14 more
doaj   +1 more source

Comparative analysis of disease burden in Sichuan Province in 2010 and 2020 based on disability-adjusted life years

open access: yesShanghai yufang yixue, 2023
ObjectiveTo analyze the disease burden in Sichuan Province in 2010 and 2020, and to provide reference for disease prevention and control.MethodsMonitoring data on causes of death in Sichuan Province in 2010 and 2020 were collected.
WEN Xiaoyan   +3 more
doaj   +1 more source

Development of a Web-based calculator to estimate DALY and Productivity Losses due to COVID-19

open access: yesClinical Epidemiology and Global Health
Objectives: Ever since the emergence of COVID-19, health and the economy worldwide have witnessed a severe disruption, with infection spreading rapidly, covering 231 countries as of May 07, 2023.
Denny John   +5 more
doaj   +1 more source

Life years lost due to cardiovascular diseases

open access: yesKardiologia Polska, 2013
When evaluating the health status of a population, an increasingly important role is played by measures aiming to access premature mortality in lost lifetime units. There is a considerable number of life years 'to be recovered' provided cardiovascular disease (CVD) mortality is reduced, as CVD cause the highest absolute number of years lost.To access ...
Irena, Maniecka-Bryła   +2 more
openaire   +2 more sources

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy